Selecting analytical biomarkers for diagnostic applications: a first principles approach. (Q50098404)

24 February 2018

review article

1 reference

title

Selecting analytical biomarkers for diagnostic applications: a first principles approach. (English)

1 reference

24 February 2018

1 reference

Samantha A Byrnes

1

1 reference

24 February 2018

Bernhard H Weigl

series ordinal

2

1 reference

24 February 2018

publication date

4 December 2017

1 reference

24 February 2018

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

published in

1 reference

24 February 2018

volume

18

1 reference

24 February 2018

page(s)

19-26

1 reference

24 February 2018

issue

1

1 reference

24 February 2018

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

copyright license

start time

9 December 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Biomarkers in Pharmaceutical Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Enabling the Development and Deployment of Next Generation Point-of-Care Diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Emerging Technologies for Next-Generation Point-of-Care Testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

From the bench to the field in low-cost diagnostics: two case studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Bead-based immunoassay allows sub-picogram detection of histidine-rich protein 2 from Plasmodium falciparum and estimates reliability of malaria rapid diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Sequence variation does not confound the measurement of plasma PfHRP2 concentration in African children presenting with severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

A nested real-time PCR assay for the quantification of Plasmodium falciparum DNA extracted from dried blood spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Use of Blood Smears and Dried Blood Spots for Polymerase Chain Reaction-Based Detection and Quantification of Bacterial Infection and Plasmodium falciparum in Severely Ill Febrile African Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Comparison of a PfHRP2-based rapid diagnostic test and PCR for malaria in a low prevalence setting in rural southern Zambia: implications for elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Distinct interethnic differences in immunoglobulin G class/subclass and immunoglobulin M antibody responses to malaria antigens but not in immunoglobulin G responses to nonmalarial antigens in sympatric tribes living in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Evaluation of the impact of universal testing for gestational diabetes mellitus on maternal and neonatal health outcomes: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Cytokines and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

The current status of cancer biomarker research using tumour-associated antigens for minimal invasive and early cancer diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Lipidomics in drug and biomarker development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Type 1 Diabetes Candidate Genes Linked to Pancreatic Islet Cell Inflammation and Beta-Cell Apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

HbA1c for screening and diagnosis of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Economic evaluation of point-of-care diagnostic technologies for infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Biomarkers for serum diagnosis of infectious diseases and their potential application in novel sensor platforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Comparison of urine, first and second endourethral swabs for PCR based detection of genital Chlamydia trachomatis infection in male patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Impact of urine collection order on the ability of assays to identify Chlamydia trachomatis infections in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Evaluation of diagnostic tests: dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Theoretical design and analysis of multivolume digital assays with wide dynamic range validated experimentally with microfluidic digital PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Ultrasensitive bioanalysis: current status and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Emerging technologies to increase ligand binding assay sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Evaluation of Multiple Immunoassay Technology Platforms to Select the Anti-Drug Antibody Assay Exhibiting the Most Appropriate Drug and Target Tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737159.2018.1412258

10.1080/14737159.2018.1412258

21 January 2018

Identifiers

DOI

1 reference

24 February 2018

PubMed ID

29200322

1 reference

24 February 2018